Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosus
Clinical trial NCT02472795 · COMPLETED
Trial details
- NCT number
- NCT02472795
- Sponsor
- Viatris Innovation GmbH
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2017-01-23
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.